Ms. Hicks joined the Center for Cancer Risk Assessment in 2017 after graduating from the University of Colorado with a Master’s in Genetic Counseling. She earned her Bachelor of Science degree in Biochemistry in 2013 from the University of Vermont. She worked as a laboratory technician in a cancer and cell biology lab at the University of Vermont before beginning graduate school. As part of CCRA, Ms. Hicks provides risk assessment and genetic counseling services in both the Breast/Ovarian and GI Cancer Genetics clinics in both Boston and Danvers. In addition, Ms. Hicks also sees patients in the Neuro-Oncology Genetics clinic. Outside of clinic, Ms. Hicks is interested in introducing the field of genetic counseling to many different audiences, especially high school and college students.
This helped lead to new knowledge and breakthrough therapies.
Our support programs can help patients and their families cope with the challenges of a cancer diagnosis.
Genetic testing for cancer risk assessment was first offered in 1996 for a limited number of genes. Many people have heard of the BRCA genes, but cancer genetics has changed significantly since 1996. Stephanie Hicks, MS, LCGC, shares more about the role of genetic testing in the cancer setting.
